Dolby Laboratories, Inc.
DLB
$61.06
-$3.44-5.33%
NYSE
| 12/26/2025 | 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | |
|---|---|---|---|---|---|
| Net Income | 53.33M | 49.33M | 46.07M | 91.79M | 67.82M |
| Total Depreciation and Amortization | 26.81M | 24.58M | 24.40M | 24.43M | 25.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.21M | 61.10M | 22.70M | 25.12M | 30.02M |
| Change in Net Operating Assets | -56.55M | -12.17M | -25.48M | 33.56M | -16.26M |
| Cash from Operations | 54.80M | 122.83M | 67.69M | 174.90M | 106.78M |
| Capital Expenditure | -4.63M | -16.24M | -6.43M | -6.90M | -6.78M |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 16.88M | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | -1.36M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.87M | -5.67M | 0.00 | 15.91M | -- |
| Cash from Investing | 1.25M | -21.91M | -6.43M | 25.90M | -8.14M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.25M | 5.02M | 12.56M | 3.97M | 22.16M |
| Repurchase of Common Stock | -101.20M | -37.08M | -41.20M | -36.77M | -47.44M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -34.34M | -31.59M | -31.63M | -31.83M | -31.55M |
| Other Financing Activities | -547.00K | -398.00K | -468.00K | -241.00K | -740.00K |
| Cash from Financing | -121.83M | -64.06M | -60.74M | -64.87M | -57.57M |
| Foreign Exchange rate Adjustments | -5.00K | -67.00K | 5.70M | 2.77M | -7.16M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -65.80M | 36.80M | 6.22M | 138.69M | 33.91M |